BioXcel Therapeutics
BTAI
$1.18
Share price
-0.84%
Change (1 day)
-93.26%
Change (1 year)
Categories
BioXcel Therapeutics (BTAI) Fails to deliver data
Key failure to deliver metrics for BioXcel Therapeutics:
- Last SEC data release: 2024-05-31
- Last 15 days FTD volume: $0.06 M
- Last 3 months FTD volume: $2.55 M
- Last year FTD volume: $91.4 M
Failures to deliver for BioXcel Therapeutics (BTAI) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for BioXcel Therapeutics (BTAI) - since 2018
Volume in USD (price x number of shares), data since 2018BioXcel Therapeutics (BTAI) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $24.64 M | -67.85% |
| 2023 | $76.65 M | 331.84% |
| 2022 | $17.75 M | 36.6% |
| 2021 | $12.99 M | -3.8% |
| 2020 | $13.5 M | 120.5% |
| 2019 | $6.12 M | 54.66% |
| 2018 | $3.96 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $1.67 M | $7.03 M | 🇺🇸 USA |